FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like Patent Thickets are Thwarting U.S. Availability of Lower-Cost Biosimilars, Study Finds January 19, 2022 Gilead, Hutchmed Unveil Positive Phase 3 Oncology Data at European Meeting September 8, 2022 FDA Issues Revised Guidance on Developing Drugs for Complicated UTIs June 1, 2018
Patent Thickets are Thwarting U.S. Availability of Lower-Cost Biosimilars, Study Finds January 19, 2022